Real-time enrollment status for this triple negative breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:48 PM UTC
| NCT Number | NCT07066189 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 160 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Yale University |
| Last Updated on CT.gov | October 29, 2025 (Oct 29, 2025) |
As of July 13, 2026: Clinical trial NCT07066189 is currently recruiting participants. This clinical trial study for triple negative breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Yale University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07066189 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07066189 was last updated Oct 29, 2025 (October 29, 2025). HelloStudys verifies this status automatically.